LFF
ACOR

Level Four Financial’s Acorda Therapeutics ACOR Stock Holding History

Level Four Financial’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-250
Closed -$21K – 371
2020
Q4 		$21K Buy
+250
New +$23K 0.01% 303

Other funds holding ACOR

Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
CCA
Canyon Capital Advisors Dallas, Texas $772M AUM 32.81% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Level Four Financial's ACOR Position: Q1 2021 in Review

Level Four Financial sold out of Acorda Therapeutics (ACOR) in Q1 2021, closing a stake of 250 shares — an estimated $21K sold.

Level Four Financial first reported a position in ACOR in Q4 2020 and held it in 1 quarter. The position peaked at $21K in Q4 2020. 32 funds tracked by Wall St. Rank hold ACOR as of Q1 2021.

  • Level Four Financial reported no remaining Acorda Therapeutics position as of Q1 2021 after selling out during the quarter.
  • Level Four Financial sold 250 Acorda Therapeutics shares in Q1 2021, an estimated $21K.
  • Level Four Financial first reported a position in Acorda Therapeutics in Q4 2020 and held it in 1 quarter.
  • Level Four Financial's Acorda Therapeutics position peaked at $21K in Q4 2020.
  • 32 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q1 2021.

Based on Level Four Financial's 13F filing for Q1 2021, filed 10 May 2021.